Something to Sweat About: Two Cases of Dupilumab-Induced Hyperhidrosis and Bromhidrosis.
Marija J RowaneReimus ValenciaJason SchendDevi JhaveriRobert HostofferPublished in: Allergy & rhinology (Providence, R.I.) (2020)
We report improved outcomes with dupilumab, in addition to unpublished cases of bromhidrosis and hyperhidrosis in 2 patients with AD. This report of additional complications may inspire further clinical research and assist clinicians in considering the option of dupilumab for uncontrolled AD, despite aggressive traditional treatment.